Nicosia, Cyprus

Elena Kypri

This inventor holds 7 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: Nipd Genetics Public Company Ltd, Medicover Public Co Ltd. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elena Kypri. Retrieved from https://idiyas.com/inventor/elena-kypri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.3

ph-index = 1


Location History:

  • Nicosia, CY (2021 - 2023)
  • Nico, CY (2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Elena Kypri

Introduction

Elena Kypri is a prominent inventor based in Nicosia, Cyprus. She has made significant contributions to the field of biotechnology, particularly in the assessment of tumor biomarkers and non-invasive prenatal testing. With a total of six patents to her name, her work has the potential to impact medical diagnostics and treatment.

Latest Patents

One of her latest patents is titled "Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers." This invention provides methods for assessing tumor biomarkers using target-enriched multiplexed parallel analysis. The methods utilize Target Capture Sequences (TACS) to enrich for target sequences of interest, followed by massive parallel sequencing and statistical analysis of the enriched population. These methods can be applied to DNA samples from patients, such as tissue biopsies or plasma samples, for the detection of tumor biomarkers, aiding in diagnosis, screening, therapy selection, and treatment monitoring. Additionally, kits for carrying out these methods are also provided.

Another significant patent is "Multiplexed parallel analysis of targeted genomic regions for non-invasive prenatal testing." This invention offers methods for non-invasive prenatal testing that detect risks of chromosomal and subchromosomal abnormalities, including aneuploidies, microdeletions, and small-size mutations. The methods utilize a pool of TArget Capture Sequences (TACS) to enrich for sequences of interest in a mixed sample containing both maternal and fetal DNA. This is followed by massive parallel sequencing and statistical analysis to detect the risk of genetic abnormalities in fetal DNA. Kits for implementing these methods are also included.

Career Highlights

Elena Kypri has worked with notable companies such as Nipd Genetics Public Company Ltd and Medicover Public Company Ltd. Her experience in these organizations has contributed to her expertise in the field of genetic testing and diagnostics.

Collaborations

Elena has collaborated with professionals like George Koumbaris and Philippos C Patsalis, enhancing her research and development efforts in biotechnology.

Conclusion

Elena Kypri's innovative work in the field of biotechnology, particularly in tumor biomarker assessment and prenatal testing, showcases her significant contributions to medical science. Her patents reflect her commitment to advancing healthcare through technology and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…